Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale.
Int J Infect Dis
; 104: 108-110, 2021 Mar.
Article
in English
| MEDLINE | ID: covidwho-988033
ABSTRACT
Existing literature highlights the fact that patients with COVID-19 exhibit alterations in the coagulation process and are associated with respiratory and cardiovascular diseases, including acute respiratory distress syndrome and acute cor pulmonale. In this report, we describe the effects of systemic thrombolysis on acute cor pulmonale in a patient suffering from COVID-19. We demonstrated that systemic thrombolysis successfully improved the hemodynamics of our patient and resulted in a prominent reduction in hypercapnia, alveolar dead space, and ventilatory ratio.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Respiratory Distress Syndrome
/
Thrombolytic Therapy
/
Tissue Plasminogen Activator
/
SARS-CoV-2
/
COVID-19
/
Heart Failure
Type of study:
Case report
Topics:
Long Covid
Limits:
Aged
/
Humans
/
Male
Language:
English
Journal:
Int J Infect Dis
Journal subject:
Communicable Diseases
Year:
2021
Document Type:
Article
Affiliation country:
J.ijid.2020.12.043
Similar
MEDLINE
...
LILACS
LIS